Jean Y. Tang MD PhD

Publication Details

  • Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened.

    Tang T, Tang JY, Li D, Reich M, Callahan CA, Fu L, Yauch RL, Wang F, Kotkow K, Chang KS, Shpall E, Wu A, Rubin LL, Marsters JC, Epstein EH, Caro I, de Sauvage FJ. Clin Cancer Res. 2011; 17 (10): 3378-87

    Inappropriate activation of the Hedgehog (Hh) signaling pathway in skin is critical for the development of basal cell carcinomas (BCC). We have investigated the anti-BCC efficacy of topically-applied CUR61414, an inhibitor of the Hh signal transduction molecule Smoothened.

    PubMedID: 21558397

Stanford Medicine Resources:

Footer Links: